Literature DB >> 8526833

Evaluation of the Lake Louise acute mountain sickness scoring system in a hypobaric chamber.

G Savourey1, A Guinet, Y Besnard, N Garcia, A M Hanniquet, J Bittel.   

Abstract

This study evaluated the relevance of the Lake Louise acute mountain sickness (AMS) scoring system in comparison with other AMS scoring systems. To achieve this objective nine subjects were submitted to a 9-hr exposure to hypoxia in a hypobaric chamber (altitude 4500-5500 m) that led to the development of AMS. AMS was scored at the end of this exposure period both by questionnaires (Hackett AMS questionnaire, Lake Louise AMS self-report questionnaire, Environmental Symptoms Questionnaire ESQ II and ESQ IV) and by a clinical investigation following the Lake Louise AMS clinical and functional AMS assessment. The AMS scores were between 0 and 9 for the Hackett AMS score, 0 and 38 for the ESQ II AMS score, 0 and 13.7 for the ESQ IV AMS score, 0 and 10 for the Lake Louise AMS self-report, 0 and 2 for the Lake Louise AMS clinical assessment score, and between 0 and 2 for the Lake Louise functional score. All the AMS questionnaire scores were related to the clinical AMS assessment score (p < 0.05) without significant differences between them. The Lake Louise AMS self-report score appeared highly correlated to other AMS scoring systems (Hackett, ESQ II and ESQ IV) (p < 0.05). Suggestions were proposed to improve the sensitivity and the specificity of the Lake Louise AMS scoring questionnaire but also the Lake Louise AMS clinical assessment. In conclusion, this study suggests the relevance of the Lake Louise AMS self-report questionnaire to assess and score AMS with simplicity and rapidity.

Entities:  

Mesh:

Year:  1995        PMID: 8526833

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  16 in total

1.  The effect of 18 h of simulated high altitude on left ventricular function.

Authors:  Jesper Kjaergaard; Eric M Snyder; Christian Hassager; Thomas P Olson; Jae K Oh; Bruce D Johnson
Journal:  Eur J Appl Physiol       Date:  2006-09-21       Impact factor: 3.078

2.  Ambulatory and central haemodynamics during progressive ascent to high-altitude and associated hypoxia.

Authors:  M G Schultz; R E D Climie; J E Sharman
Journal:  J Hum Hypertens       Date:  2014-03-13       Impact factor: 3.012

3.  Influence of Inhaled Amiloride on Lung Fluid Clearance in Response to Normobaric Hypoxia in Healthy Individuals.

Authors:  Courtney M Wheatley; Sarah E Baker; Bryan J Taylor; Manda L Keller-Ross; Steven C Chase; Alex R Carlson; Robert J Wentz; Eric M Snyder; Bruce D Johnson
Journal:  High Alt Med Biol       Date:  2017-09-06       Impact factor: 1.981

4.  Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humans.

Authors:  Eric M Snyder; Richard D Carr; Carolyn F Deacon; Bruce D Johnson
Journal:  Appl Physiol Nutr Metab       Date:  2008-10       Impact factor: 2.665

5.  Normo or hypobaric hypoxic tests: propositions for the determination of the individual susceptibility to altitude illnesses.

Authors:  Gustave Savourey; Jean-Claude Launay; Yves Besnard; Angélique Guinet-Lebreton; Antonia Alonso; Fabien Sauvet; Cyprien Bourrilhon
Journal:  Eur J Appl Physiol       Date:  2007-02-24       Impact factor: 3.346

6.  Polymorphisms of the tissue inhibitor of metalloproteinase 3 gene are associated with resistance to high-altitude pulmonary edema (HAPE) in a Japanese population: a case control study using polymorphic microsatellite markers.

Authors:  Nobumitsu Kobayashi; Masayuki Hanaoka; Yunden Droma; Michiko Ito; Yoshihiko Katsuyama; Keishi Kubo; Masao Ota
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

7.  Pupillary light reaction during high altitude exposure.

Authors:  Maximilian Schultheiss; Kai Schommer; Andreas Schatz; Barbara Wilhelm; Tobias Peters; M Dominik Fischer; Eberhart Zrenner; Karl U Bartz-Schmidt; Florian Gekeler; Gabriel Willmann
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

8.  Risk prediction score for severe high altitude illness: a cohort study.

Authors:  Florence Canouï-Poitrine; Kalaivani Veerabudun; Philippe Larmignat; Murielle Letournel; Sylvie Bastuji-Garin; Jean-Paul Richalet
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

9.  Evaluation of the visual analog score (VAS) to assess acute mountain sickness (AMS) in a hypobaric chamber.

Authors:  Jialin Wu; Yu Chen; Yongjun Luo
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

10.  Short-term high-altitude pre-exposure improves neurobehavioral ability.

Authors:  Wenyun Guo; Guozhu Chen; Jun Qin; Jihang Zhang; Xubin Guo; Jie Yu; Pan Song; Wei Lu; Baida Xu; Jiabei Li; Xiaohan Ding; Lan Huang
Journal:  Neuroreport       Date:  2016-04-13       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.